Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00ASA
|
|||
Former ID |
DNC011722
|
|||
Drug Name |
2-(3-Chloro-phenyl)-chromen-4-one
|
|||
Synonyms |
CHEMBL56414; 2-(3-chlorophenyl)chromen-4-one; 1849-61-2; 4h-1-benzopyran-4-one,2-(3-chlorophenyl)-; AC1LAD8B; 2-(3-CHLOROPHENYL)-4H-CHROMEN-4-ONE; SCHEMBL6655676; ZINC6583548; MB10491; 2-(3'-chlorophenyl)-4h-chromen-4-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H9ClO2
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C(=O)C=C(O2)C3=CC(=CC=C3)Cl
|
|||
InChI |
1S/C15H9ClO2/c16-11-5-3-4-10(8-11)15-9-13(17)12-6-1-2-7-14(12)18-15/h1-9H
|
|||
InChIKey |
JWTQJUQJIRWZLA-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | GABA(A) receptor alpha-1 (GABRA1) | Target Info | Inhibitor | [1] |
Gamma-aminobutyric acid receptor (GAR) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Retrograde endocannabinoid signaling | ||||
GABAergic synapse | ||||
Morphine addiction | ||||
Nicotine addiction | ||||
Reactome | Ligand-gated ion channel transport | |||
GABA A receptor activation | ||||
WikiPathways | SIDS Susceptibility Pathways | |||
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | ||||
Iron uptake and transport |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis of halogenated/nitrated flavone derivatives and evaluation of their affinity for the central benzodiazepine receptor, Bioorg. Med. Chem. Lett. 7(15):2003-2008 (1997). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.